Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis.


Department of Health Economics, Corvinus University of Budapest, Budapest, Hungary. [Email]


Synthesis of evidence on the long-term use of first-line biologic therapy in patients with early rheumatoid arthritis (RA) is required. We compared the efficacy of up to 5 years' treatment with first-line tumor necrosis factor inhibitors (TNFis) versus other treatment strategies in this population.


Biologic,Disease-modifying antirheumatic drug,Early,Efficacy,First line,Meta-analysis,Methotrexate-naïve,Systematic review,Tumor necrosis factor inhibitor,